Welcome to Helsinn’s LinkedIn page. This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology. Helsinn, headquartered in Lugano, Switzerland, has direct commercial operations in the U.S. and an extensive network of long-standing trusted partners enabling a commercial presence in more than 90 countries. Established in 1976, Helsinn is a third-generation family-owned company with broad pharmaceutical and technical expertise. Helsinn is proud of its history of operating with great integrity, passion and quality. The company is committed to continuously striving for innovation for its patients and embracing sustainable growth as a core element of its strategic vision. If you are interested in joining Helsinn or one of our affiliates, please visit helsinn.com. Applications should only be submitted via the appropriate country portal under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact: Switzerland: info-HHC@helsinn.com, U.S.: HTU-HR@helsinn.com, Ireland: info-hbp@helsinn.com. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED]
View Top Employees from Helsinn GroupWebsite | http://www.helsinn.com |
Revenue | $125 million |
Funding | $10.8 million |
Employees | 439 (439 on RocketReach) |
Founded | 1976 |
Address | 9 Via Pian Scairolo, Pazzallo, Ticino 6912, CH |
Phone | +41 91 873 94 00 |
Fax | +41 91 873 01 11 |
Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Health Care, Licensing of pharmaceuticals, medical devices and nutritional su, Healthcare, Pharmaceutical, Therapeutics |
Keywords | Oncology, Biopharmaceuticals, Drug Development And Manufacturing, Cancer Therapeutics |
Competitors | Fermion Oy, Laurus Labs Limited, Noramco™, ScinoPharm Taiwan Ltd, Vivimed Labs Limited |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies |
Looking for a particular Helsinn Group employee's phone or email?
The Helsinn Group annual revenue was $125 million in 2024.
Giorgio Calderari is the Vice Chairman Board Directors of Helsinn Group.
439 people are employed at Helsinn Group.
Helsinn Group is based in Pazzallo, Ticino.
The NAICS codes for Helsinn Group are [54, 5417, 54171, 541711, 541].
The SIC codes for Helsinn Group are [283, 28].